Corrigendum: Treating experimental arthritis with the innate immune inhibitor interleukin-37 reduces joint and systemic inflammation [Rheumatology, 55, (2016), (2220-2229)] doi:10.1093/rheumatology/kew325

Giulio Cavalli, Marije Koenders, Vassili Kalabokis, Jihye Kim, Aik-Choon Tan, Cecilia Garlanda, Alberto Mantovani, Lorenzo Dagna, Leo A.B. Joosten, Charles A. Dinarello

Research output: Contribution to journalComment/debate

9 Citations (Scopus)

Abstract

The Authors report that the picture originally included in the manuscript as Figure 1A was mistakenly chosen and does not depict the knee joint of a mouse treated with IL-37, but rather with a different molecule, which was coincidently being tested in our laboratory as a treatment for arthritis. The same investigator acquired photographs from separate experiments with the same camera device, and images were mixed up because joint swelling scores were equal and the depicted findings were clinically indistinguishable. The correct Figure 1A is provided hereby and has been corrected online.

Original languageEnglish
Number of pages1
JournalRheumatology (United Kingdom)
Volume56
Issue number12
DOIs
Publication statusPublished - 2017 Dec 1
Externally publishedYes

ASJC Scopus subject areas

  • Rheumatology
  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'Corrigendum: Treating experimental arthritis with the innate immune inhibitor interleukin-37 reduces joint and systemic inflammation [Rheumatology, 55, (2016), (2220-2229)] doi:10.1093/rheumatology/kew325'. Together they form a unique fingerprint.

  • Cite this